IRIS
VIAZZI, FRANCESCA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.634
AS - Asia 2.881
NA - Nord America 1.403
SA - Sud America 281
AF - Africa 56
OC - Oceania 9
Totale 29.264
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 24.074
US - Stati Uniti d'America 1.327
SG - Singapore 1.306
CN - Cina 787
VN - Vietnam 476
FR - Francia 229
BR - Brasile 170
HK - Hong Kong 107
FI - Finlandia 101
DE - Germania 64
AR - Argentina 59
MX - Messico 37
IN - India 35
BD - Bangladesh 33
GB - Regno Unito 32
JP - Giappone 30
IQ - Iraq 24
CH - Svizzera 23
ID - Indonesia 20
CA - Canada 18
NL - Olanda 16
ZA - Sudafrica 16
EC - Ecuador 12
ES - Italia 12
IE - Irlanda 11
RU - Federazione Russa 11
VE - Venezuela 11
CO - Colombia 10
AU - Australia 8
CL - Cile 8
PH - Filippine 8
PK - Pakistan 8
MA - Marocco 7
PL - Polonia 7
SA - Arabia Saudita 7
UA - Ucraina 7
DZ - Algeria 6
AT - Austria 5
CR - Costa Rica 5
EG - Egitto 5
PY - Paraguay 5
RO - Romania 5
SN - Senegal 5
TR - Turchia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
SE - Svezia 4
TH - Thailandia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
AL - Albania 2
CI - Costa d'Avorio 2
GA - Gabon 2
GY - Guiana 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
LI - Liechtenstein 2
MK - Macedonia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MR - Mauritania 1
MY - Malesia 1
OM - Oman 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 29.261
Salva come PNG Salva come JPEG
Città #
Genova 12.477
Genoa 7.785
Vado Ligure 1.851
Rapallo 1.753
Singapore 648
San Jose 460
Lauterbourg 216
Council Bluffs 188
Ashburn 184
Ho Chi Minh City 151
Beijing 114
Hong Kong 103
Hanoi 101
Helsinki 88
New York 76
Frankfurt am Main 46
Santa Clara 46
Bordighera 43
St Louis 30
Tokyo 26
Milan 25
Los Angeles 23
Mexico City 23
Zurich 23
Haiphong 20
Orem 20
São Paulo 20
Da Nang 17
Tianjin 16
Rome 14
Lappeenranta 12
Dublin 11
Amsterdam 10
Biên Hòa 10
Chennai 9
Chicago 9
Dallas 9
Buenos Aires 8
Buffalo 8
Johannesburg 8
Nuremberg 8
Atlanta 7
Baghdad 7
City of London 7
Hải Dương 7
London 7
Montreal 7
Naples 7
Rio de Janeiro 7
Shanghai 7
Guangzhou 6
Paris 6
San José 6
Bắc Ninh 5
Cardiff 5
Dakar 5
Mumbai 5
Quảng Ngãi 5
Salt Lake City 5
Suzhou 5
Sydney 5
Thái Bình 5
Toronto 5
Bogotá 4
Bình Phước 4
Dhaka 4
Florence 4
Fortaleza 4
Guayaquil 4
Hưng Yên 4
Jakarta 4
Kyiv 4
Laferrere 4
Madrid 4
Nairobi 4
Quận Ba 4
San Juan 4
Santiago 4
Tampa 4
Turin 4
Amman 3
Asunción 3
Bari 3
Basingstoke 3
Beirut 3
Boardman 3
Bologna 3
Bonito 3
Brantford 3
Brooklyn 3
Campinas 3
Cape Town 3
Caracas 3
Charlotte 3
Copenhagen 3
Des Moines 3
Goiânia 3
Linfen 3
Moscow 3
Philadelphia 3
Totale 26.948
Salva come PNG Salva come JPEG
Nome #
MicroRaman spectroscopy detects the presence of microplastics in human urine and kidney tissue 422
Homocysteine exchange across skeletal muscle in patients with chronic kidney disease 310
Left ventricular dilatation and subclinical renal damage in primary hypertension 248
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years. 212
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 205
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 205
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 205
Interorgan handling of fibroblast growth factor-23 in humans 202
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 199
Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis. 199
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 194
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 193
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 192
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 190
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 184
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 183
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 182
Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease 181
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 178
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 177
C-reactive protein and target organ damage in untreated patients with primary hypertension. 176
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 175
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 174
Cardiovascular and renal effects of hyperuricaemia and gout. 172
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 171
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 170
Novelty in hypertension in children and adolescents: Focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors 168
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 168
Endothelin-1/nitric oxide balance and HOMA index in children with excess weight and hypertension: a pathophysiological model of hypertension 167
The Organ Handling of Soluble Klotho in Humans 167
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 166
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 164
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 164
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 163
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 163
#6111 FIRST IDENTIFICATION AND CHARACTERIZATION OF MICROPLASTICS IN HUMAN KIDNEY AND URINE 163
Blood pressure variability and multiple organ damage in primary hypertension 162
Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria 162
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 162
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 161
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 160
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 159
Microalbuminuria in primary hypertension: a guide to optimal patient management? 159
The control of muscle protein turnover in patients on peritoneal dialys 159
Creatinine clearance and early signs of target organ damage in primary hypertension 152
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 151
Sub-clinical organ damage in hypertension and obesity 149
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 148
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 148
Renal and cardiac abnormalities in primary hypertension 148
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 148
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 148
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 147
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 147
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 147
Albuminuria: The kidney message on cardiovascular health 145
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 145
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 145
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 145
Mild renal dysfunction and renal vascular resistance in primary hypertension 144
Hyperuricemia and renal risk 144
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 143
Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis 143
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 143
We are far from achieving blood pressure goals in diabetes: Do we really want to do it? 143
Low protein diets and plant-based low protein diets: Do they meet protein requirements of patients with chronic kidney disease? 143
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 142
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 142
Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports 140
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 140
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 140
Overall health assessment: a renal perspective. 140
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 140
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease 140
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 139
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 138
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 138
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 138
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 138
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 138
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 137
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 137
Chronic kidney disease and albuminuria in arterial hypertension. 136
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 134
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 133
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 133
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 133
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes 133
Serum uric acid as a marker of target organ damage in primary hypertension 131
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 131
RAAS Inhibition and Renal Protection 130
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 130
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 130
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 130
Antihypertensive therapy in hypertensive patients with metabolic syndrome. 129
Serum Uric Acid and Blood Pressure in Children at Cardiovascular Risk 128
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 126
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 126
Global risk stratification in primary hypertension: the role of the kidney 125
Metabolic syndrome, serum uric acid and renal risk in patients with T2D 125
Totale 16.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.571
article - articoli 93.058
book - libri 0
conference - conferenze 744
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.769
Totale 191.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021555 0 0 0 0 0 0 0 0 0 239 127 189
2021/20222.261 98 98 107 231 90 236 130 528 130 253 81 279
2022/20232.159 206 139 20 229 325 378 31 173 380 29 209 40
2023/20241.498 68 162 43 191 125 277 94 103 64 35 110 226
2024/20255.367 139 326 192 320 610 480 442 759 204 338 585 972
2025/20268.015 941 338 760 844 1.032 733 1.389 434 632 912 0 0
Totale 29.969